Identification of a mitochondrial-binding site on the N-terminal end of hexokinase II
Authors:
Open Access
- 1 June 2015
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 35 (3)
Abstract
Hexokinase II (HKII) is responsible for the first step in the glycolysis pathway by adding a phosphate on to the glucose molecule so it can proceed down the pathway to produce the energy for continuous cancer cell growth. Tumour cells overexpress the HKII enzyme. In fact, it is the overexpression of the HKII enzyme that makes the diagnosis of cancer possible when imaged by positron emission tomography (PET). HKII binds to the voltage-dependent anion channel (VDAC) located on the mitochondrial outer membrane (MOM). When bound to the MOM, HKII is blocking a major cell death pathway. Thus, HKII is responsible for two characteristics of cancer cells, rapid tumour growth and inability of cancer cells to undergo apoptosis. One method to identify novel compounds that may interfere with the HKII–VDAC-binding site is to create a molecular model using the crystal structure of HKII. However, the amino acid(s) responsible for HKII binding to VDAC are not known. Therefore, a series of truncations and point mutations were made to the N-terminal end of HKII to identify the binding site to VDAC. Deletions of the first 10 and 20 amino acids indicated that important amino acid(s) for binding were located within the first 10 amino acids. Next, a series of point mutations were made within the first 10 amino acids. It is clear from the immunofluorescence images and immunoblot results that mutating the fifth amino acid from histidine to proline completely abolished binding to the MOM.Keywords
This publication has 35 references indexed in Scilit:
- Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanismCell Cycle, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Downregulation of the Hexokinase II Gene Sensitizes Human Colon Cancer Cells to 5-FluorouracilChemotherapy, 2008
- Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion ChannelsPLOS ONE, 2008
- Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and IIMolecular and Cellular Biology, 2008
- The High Resolution Crystal Structure of Yeast Hexokinase PII with the Correct Primary Sequence Provides New Insights into Its Mechanism of ActionJournal of Biological Chemistry, 2000
- Regulation of hexokinase I: crystal structure of recombinant human brain hexokinase complexed with glucose and phosphate 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1998
- Functional Organization of Mammalian Hexokinase IIJournal of Biological Chemistry, 1996
- Pore protein and the hexokinase‐binding protein from the outer membrane of rat liver mitochondria are identicalFEBS Letters, 1982
- On the Origin of Cancer CellsScience, 1956